Dorzolamide hydrochloride (Synonyms: 盐酸多佐胺; L671152 hydrochloride; MK507 hydrochloride)
目录号: PL05254 纯度: ≥99%
CAS No. :130693-82-2
商品编号 规格 价格 会员价 是否有货 数量
PL05254-10mg 10mg ¥865.45 请登录
PL05254-50mg 50mg ¥1730.91 请登录
PL05254-100mg 100mg ¥2101.82 请登录
PL05254-200mg 200mg 询价 询价
PL05254-500mg 500mg 询价 询价
PL05254-10mM*1mLinDMSO 10mM*1mLinDMSO ¥952.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
Dorzolamide hydrochloride
中文别名
盐酸多佐胺;盐酸杜塞酰胺;(2S,4S)-2-乙基氨基-4-甲基-5,5-二氧-5,7-二硫双环[4.3.0]壬-8,10-二烯-8-磺酰胺盐酸盐;盐酸多佐胺(青光眼治疗药);多佐胺-2-7;盐酸多佐胺(杜塞酰胺);盐酸多佐胺, 盐酸杜塞酰胺;盐酸多佐胺及中间体;Dorzolamide Hydrochloride 盐酸多佐胺;多佐胺;多佐胺系统适用性 EP标准品;多佐胺盐酸盐;抗青光眼药盐酸多佐胺;三唾液酸神经节苷酯;盐酸多佐胺 Dorzolomide hydrochloride;盐酸多佐胺 EP标准品;盐酸多佐胺 USP标准品;盐酸多佐胺 标准品;盐酸多佐胺标准品(JP);盐酸杜塞酰胺(标准品)
英文名称
Dorzolamide hydrochloride
英文别名
Dorzolomide hydrochloride;3-b)thiopyran-2-sulfonamide,5,6-dihydro-4-(ethylamino)-6-methyl-4h-thieno(;mk-0507;monohydrochloride,(4s-trans)-7-dioxide;(2s,4s)-2-ethylamino-4-methyl-5,5-dioxo-5,7-dithiabicyclo[4.3.0]nona-8,10-diene-8-sulfonamide hydrochloride;DORZOLAMIDE HCL;DORZOLAMIDE HYDROCHLORIDE;DorzolomideHcl,Usp;4H-Thieno[2,3-b]thiopyran-2-sulfonamide, 4-(ethylamino)-5,6-dihydro-6-methyl-, 7,7-dioxide, hydrochloride (1:1), (4S,6S)-;Dorzolamide;Dorzolamide (hydrochloride);L671152 hydrochloride;MK507 hydrochloride;MK 507;Trusopt;Biosopt;L 671152;Dorzalamide;Dorzolamide HCI;Dorzolamide hydrochloride;(2S,4S)-2-Ethylamino-4-methyl-5,5-dioxo-5,7-dithiabicyclo[4.3.0]nona-8,10-diene-8-sulfonamide hydrochloride
Cas No.
130693-82-2
分子式
C10H16N2O4S3.HCl
分子量
360.89
包装储存
4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
产品详情
Dorzolamide (L671152) hydrochloride 是有效的碳酸酐酶 carbonic anhydrase II 的抑制剂,其对红细胞CA-II 和CA-I 的 IC50 值分别为 0.18 nM 和 600 nM。
生物活性
Dorzolamide (L671152) hydrochloride is a potent carbonic anhydrase II inhibitor, with IC 50 values of 0.18 nM and 600 nM for red blood cell CA-II and CA-I respectively. Dorzolamide possesses anti-tumor activity.
性状
Solid
体外研究(In Vitro)
Component A, caused by an inward flux of CO2 and its subsequent hydration by CA-II, is blocked by Dorzolamide in a dose-dependent manner with an 50% inhibitory concentration IC50 of 2.4 μM (95% confidence interval: 0.5-10.85 μM).
has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
Dorzolamide (3, 10, or 30 mg/kg/day, ip) synergized mitomycin C exhibits anti-tumor activity in EAC solid tumor models. Dorzolamide produces a dose-dependent decrease in the calculated ratio (relative value of 57.3±1, 25.5±1.8, and 24.3± 0.7 %, respectively).
has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
ClinicalTrial
参考文献
[1]. J Biollaz, et al. Whole-blood pharmacokinetics and metabolic effects of the topical carbonic anhydrase inhibitor dorzolamide. Eur J Clin Pharmacol. 1995;47(5):455-60.
[2]. Sangly P Srinivas, et al. Inhibition of carbonic anhydrase activity in cultured bovine corneal endothelial cells by dorzolamide. Invest Ophthalmol Vis Sci. 2002 Oct;43(10):3273-8.
溶解度数据
In Vitro: DMSO : 100 mg/mL (277.09 mM; Need ultrasonic)H2O : 12.5 mg/mL (34.64 mM; Need ultrasonic)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2